Live feed
Filing
SC 13D
SC 13D0001683168-20-000074·JK BioPharma Solutions, Inc
Schedule 13D ownership disclosure
NEUROBO PHARMACEUTICALS INC
Security class unavailable · CUSIP: 64132R107
Event date: 2019-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001683168-20-000074
- Form type
- SC 13D
- Filer
- JK BioPharma Solutions, Inc
- CIK
- CIK 1590304
- Filed
- Jan 10, 2020
- Reporting period
- Dec 30, 2019
- Description
- Schedule 13D beneficial ownership